SCHEMBL5509822

SCHEMBL5509822

CNCC(CC1CCC(C)CC1)NC(=O)N1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5511519 1.00 REN (0.45) REN
SCHEMBL5503829 0.91 REN (0.52) REN
SCHEMBL1866281 0.91 REN (0.52) REN
SCHEMBL5505794 0.91 REN (0.52) REN
SCHEMBL1865703 0.91 REN (0.52) REN
SCHEMBL5509831 0.91 REN (0.52) REN
SCHEMBL5508396 0.88 REN (0.44) REN
SCHEMBL5503863 0.88 REN (0.44) REN
SCHEMBL5507357 0.88 REN (0.44) REN
SCHEMBL5508879 0.86 REN (0.47) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed